Cite
The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
MLA
Weissmann, Marina, et al. “The Heparanase Inhibitor PG545 Is a Potent Anti-Lymphoma Drug: Mode of Action.” Matrix Biology, vol. 77, Apr. 2019, pp. 58–72. EBSCOhost, https://doi.org/10.1016/j.matbio.2018.08.005.
APA
Weissmann, M., Bhattacharya, U., Feld, S., Hammond, E., Ilan, N., & Vlodavsky, I. (2019). The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action. Matrix Biology, 77, 58–72. https://doi.org/10.1016/j.matbio.2018.08.005
Chicago
Weissmann, Marina, Udayan Bhattacharya, Sari Feld, Edward Hammond, Neta Ilan, and Israel Vlodavsky. 2019. “The Heparanase Inhibitor PG545 Is a Potent Anti-Lymphoma Drug: Mode of Action.” Matrix Biology 77 (April): 58–72. doi:10.1016/j.matbio.2018.08.005.